Full Name | Basem Fanous |
---|---|
Gender | Male |
Speciality | |
Experience | Years |
Location | Hwy 281n, Cando, North Dakota |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1336173871 | NPI | - | NPPES |
25667 | Other | ND | BCBS PROVIDER # |
25923 | Other | ND | BCBS PROVIDER # |
17592 | Medicaid | ND |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
213E00000X | Podiatrist | 32 (North Dakota) | Primary |
Mailing Address | Practice Location Address |
---|---|
Basem Fanous, DPM Po Box 688, Cando, ND 58324-0688 Ph: (701) 968-2541 | Basem Fanous, DPM Hwy 281n, Cando, ND 58324-0688 Ph: (701) 968-2541 |
News Archive
Some disease-causing bacteria are becoming resistant to antibiotics because they have peculiar sex lives, say researchers publishing new results today in the journal Science.
Novel treatments that harness the body's own immune cells to attack cancer cells demonstrate safe and durable responses in patients with relapsed and treatment-resistant blood cancers, according to data presented today at the 56th American Society of Hematology Annual Meeting and Exposition.
Decision Resources, Inc., a research and advisory firm focusing on pharmaceutical and healthcare issues, finds that first-in-class targeted biologics will enter the malignant melanoma market during the next five years.
Investigators at Burnham Institute for Medical Research (Burnham) and colleagues have identified a novel mouse gene (Rps23r1) that reduces the accumulation of two toxic proteins that are major players in Alzheimer's disease: amyloid beta and tau. The amyloid and tau lowering functions of this gene were demonstrated in both human and mouse cells.
› Verified 9 days ago